Lv0
0 积分 2023-04-04 加入
Targeting TL1A and DR3: the new frontier of anti-cytokine therapy in IBD
1小时前
待确认
Transmembrane domain–driven PD-1 dimers mediate T cell inhibition
4小时前
已完结
Anti–PD-1 antibodies recognizing the membrane-proximal region are PD-1 agonists that can down-regulate inflammatory diseases
4小时前
已完结
Application of CAR‐T cell technology in autoimmune diseases and human immunodeficiency virus infection treatment
3个月前
已完结
Achievable but elusive: LLDAS and DORIS remission in clinical trials of belimumab
3个月前
已关闭
Antibody-Mediated Coengagement of FcγRIIb and B Cell Receptor Complex Suppresses Humoral Immunity in Systemic Lupus Erythematosus
6个月前
已完结
Discovery of ABBV-154, an anti-TNF Glucocorticoid Receptor Modulator Immunology Antibody-Drug Conjugate (iADC)
6个月前
已完结
An immunomodulatory antibody–drug conjugate targeting BDCA2 strongly suppresses plasmacytoid dendritic cell function and glucocorticoid responsive genes
6个月前
已完结
Antibody drug conjugate combats inflammation
6个月前
已完结
The development of litifilimab (BIIB 059) for cutaneous and systemic lupus erythematosus
8个月前
已完结
皖公网安备34019202002308
